Shanghai, China – December 15, 2009

HD Biosciences, has announced today to enter into a partnership with DiscoveRx Corporation (Fremont, California USA), a premier provider of innovative cell based assay solutions for GPCR, Kinases, NHR and Proteases.

Via this partnership, HD Biosciences will enhance its service platforms and capabilities by obtaining access to DiscoveRx PathHunter^TM, cAMPHunter^TM cell lines and proprietary EFC chemiluminescent detection technology. Also, DiscoveRx will gain additional foothold in Chinese drug discovery markets through this collaboration.

DiscoveRx’s PathHunter^TM Beta-Arrestin and HitHunter^TM cAMP assays are homogeneous chemiluminescent assays which are rapidly becoming GPCR screening platform of choice for screening and profiling applications.

Effective immediately, clients will have free access to DiscoveRx assay technologies, platforms as well as cell lines via HDB’s research services.

For more information about this partnership or about the DiscoveRx technology, please contact:
Angela Chen, PhD MBA
Head, Business Development
HD Biosciences Co.Ltd
590 Ruiqing Road
Shanghai, 201201
PR China
TEL 86-21-51163716
angelachen@hdbiosciences.com